Mortara Instrument Inc.

Worldwide release of newest generation electrocardiograph ELI 380

Worldwide release of newest generation electrocardiograph ELI 380

ELI 380 - the latest addition to Mortara’s portfolio of innovative medical devices

MILWAUKEE – Mortara Instrument, Inc. (Mortara), a Milwaukee-based designer, developer and manufacturer of diagnostic cardiology (ECG) and patient monitoring technologies and devices, announced today the worldwide release of its next generation electrocardiograph – the ELI™ 380. The ELI 380 is the newest addition to the company’s ELI electrocardiograph product line.

Mortara is a technology leader focused on creating innovative cardiology solutions. For years, healthcare professionals have come to rely on Mortara’s ELI series of electrocardiographs for ease-of-use, flexibility, accuracy, and performance.

“The ELI 380 anticipates the needs of clinicians unlike any other comparable device currently on the market,” said Dr. Justin Mortara, CEO of Mortara. “It enables clinicians to focus on the patient rather than the electrocardiograph, improving efficiencies and creating a more positive patient experience.”

Building on its world-class leading predecessor, Mortara’s new ELI 380 is clinically superior and designed to solve common problems, as well as streamline workflow. For example, it features an easy-to-clean glass keyboard to reduce opportunities for cross-contamination in patient care areas. This innovative feature is especially timely given the Center for Disease Control and Prevention’s (CDC) recent focus on the danger associated with hospital acquired infections.

“Studies have shown that keyboards used in hospitals are major carriers of harmful bacteria,” said Mortara. “ELI 380’s capacitive glass keyboard design is a simple, common-sense innovation that will have a significant impact on the health and well being of clinicians and patients.”

In addition to the innovative capacitive glass keyboard, the ELI 380 features:
• An optimized, bar code-based workflow which eliminates time-consuming searches and makes upload of demographics simple;
• A smart battery designed for longer runtimes and shorter recharge times;
• A wireless patient cable that eliminates the need for direct patient connection to the electrocardiograph and enables easier access to patients in crowded treatment areas;
• A simplified user interface designed to give the best possible result, even with the most novice users; and
• The ability to integrate with electronic health records (EHR) systems using a direct or wireless network connection.

Mortara leads the industry in new medical devices, like the ELI 380, that are simple, integrated, user-centric and designed to meet the specific needs of clinicians and patients. Mortara is recognized as a global leader in the industry. To consistently deliver the quality products it is known for, the company manufactures its entire portfolio of products from its Milwaukee headquarters in the United States.

Release of the ELI 380 illustrates Mortara’s ongoing commitment to offering innovative features throughout its product range that are designed to improve the lives of patients and health care workers. In particular, Mortara’s commitment to wireless technology, data integration, simplified user interaction, and above all, clinical accuracy, are at the core of its latest new device.

About the ELI series of electrocardiographs
The ELI™ series of electrocardiographs offers a range of innovative solutions for diagnostic ECG acquisition, each one featuring the renowned Mortara VERITAS™ resting ECG interpretation algorithm. From high-volume systems to ultraportable handheld devices, ELI is the mark of dependable, robust performance built upon over 30 years of diagnostic cardiology expertise. To learn more about Mortara’s ELI series, including the ELI 380, visit www.Mortara.com.

Visit us at MEDICA Halle 09/B32

About Mortara
Mortara Instrument, Inc. was founded 30 years ago and today is a recognized technology leader in the world of ECG. Mortara’s global headquarters is located in Milwaukee, Wisconsin with operations in Australia, Germany, Italy, the Netherlands, and the United Kingdom. Mortara is distinguished in the field of non-invasive cardiology for innovations that are the core of the company's complete line of ECG products including electrocardiographs, cardiac stress exercise and rehabilitation systems, Holter systems, data warehousing solutions, and cardiology monitoring systems. The company manufactures and distributes its ECG devices and related technologies worldwide. Mortara’s market leadership is a result of its substantial investment in R & D which has fueled the introduction of many new Mortara products uniquely positioned to benefit customers in their everyday use of diagnostic ECG devices. To learn more about Mortara Instrument and its expanding product portfolio, including the Burdick and Quinton brands, visit www.mortara.com.

Media Contact:
Sondra Kaufman, (414) 362-7754